RT Journal
A1 Kadam S, Kulshrestha S, Swaminathan S
T1 B-vitamin therapy for diabetic nephropathy
JF JAMA
JO JAMA
YR 2010
FD August 11
VO 304
IS 6
SP 636
OP 637
DO 10.1001/jama.2010.1105
UL http://dx.doi.org/10.1001/jama.2010.1105
AB 
Second, inclusion criteria for this study were any diabetic patient with albuminuria greater than 300 mg per day and stage 2 or 3 chronic kidney disease. Rate of progression of chronic kidney disease is more rapid in stage 3 compared with stage 2,2- 5 so effects of B-vitamin supplementation could be different in the 2 subgroups. We would like to see the hazard ratios stratified by chronic kidney disease stage at baseline.